AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

Quarterly Report Oct 30, 2025

8725_rns_2025-10-30_7544b126-ffef-4831-bcac-ef111544783c.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2025

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

CONTENTS PAGE
INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION 1-2
INTERIM CONDENSED STATEMENT OF PROFIT OR LOSS 3
INTERIM CONDENSED STATEMENT OF OTHER COMPREHENSIVE INCOME
4
INTERIM CONDENSED STATEMENT OF CHANGES IN EQUITY
5
INTERIM CONDENSED STATEMENT OF CASH FLOWS 6
NOTES TO INTERIM CONDENSED
FINANCIAL STATEMENTS
7-45

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

Unaudited Audited
Notes 30 September 2025 31 December 2024
Assets
Current assets
Cash and cash equivalences 4 48.445 827.004
Trade receivables 1.284.254 164.572
- Trade receivables from related parties 22 147.725 53.613
- Trade receivables from third parties 7 1.136.529 110.959
Other receivables 1.534 1.913
- Other receivables from third parties 8 1.534 1.913
Inventories 9 1.123.374 990.187
Prepaid expenses 14 21.667 22.732
- Prepaid expenses from related parties 22 117 -
- Prepaid expenses from third parties 21.550 22.732
Current tax assets 14 5.771 152.651
Other current assets 28.238 89.072
- Other current assets from third parties 14 28.238 89.072
Total current assets 2.513.283 2.248.131
Non-current assets
Financial investments 5 1.564 1.637
Property, plant and equipment 10 952.385 990.762
Right of use assets 6 141.449 192.066
Intangible assets 11 118.894 111.268
Prepaid expenses 14 28.606 20.774
Deferred tax assets 20 68.304 -
Total non-current assets 1.311.202 1.316.507
Total assets 3.824.485 3.564.638

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

Unaudited Audited
Notes 30 September 2025 31 December 2024
Liabilities
Current liabilities
Current borrowings 1.553.365 489.275
-Current borrowings from third parties 1.553.365 489.275
- Bank loans 6 1.043.118 489.275
- Issued debt instruments 6 510.247 -
Current portion of long-term borrowings 470.231 139.430
-Current portion of long-term borrowings from third parties 6 470.231 139.430
- Bank loans 172.674 35.083
- Lease liabilities 45.568 59.274
- Issued debt instruments 251.989 45.073
Trade payables 169.948 166.775
- Trade payables to related parties 22 5.357 9.017
- Trade payables to third parties 7 164.591 157.758
Employee benefit obligations 8 57.102 135.620
Other payables 9.894 4.803
- Other payables to third parties 8 9.894 4.803
Derivative instruments 24.1 - 704
Deferred income 14 11.338 76.579
Short term provision 9.415 23.854
- Provisions for employment benefits 13 4.156 17.262
- Other current provisions 12 5.259 6.592
Total current liabilities 2.281.293 1.037.040
Non-current liabilities
Non-current borrowings 66.598 635.157
- Non-current borrowings from third parties 6 66.598 635.157
- Bank loans - 213.231
- Issued debt instruments - 313.575
- Lease liabilities 66.598 108.351
Employee benefit obligations 8 1.635 2.904
Non-current provisions 36.714 41.895
- Non-current provision for employee benefits 13 36.714 41.895
Deferred tax liabilities 20 - 30.053
Total non-current liabilities 104.947 710.009
Equity
Paid-in share capital 15 259.875 259.875
Adjustment to share capital 15 464.004 464.004
Other comprehensive expense not to be
reclassified to profit or loss (25.436) (18.794)
- Revaluation and measurement gains / (losses) (25.436) (18.794)
Other comprehensive expense/(income) to be
reclassified to profit or loss 15.211 15.639
- Gains/(loss) on hedge 15.211 15.639
Restricted reserves appropriated from profits 15 388.255 377.967
15 542.612 695.513
Prior years' profits/(losses)
Net profit/(loss) for the period (206.276) 23.385
Total equity 1.438.245 1.817.589

The accompanying notes form an integral part of these interim condensed financial statements.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF PROFIT OR LOSS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

Unaudited Unaudited
Profit or loss Notes 1 January - 1 January -
30 September 2025 30 September 2024 30 September 2025
1 July - 1 July -
30 September 2024
Revenue 16 1.842.427 3.119.770 811.883 1.259.782
Cost of sales (-) 16 (1.072.192) (1.516.229) (486.115) (691.699)
Gross profit 770.235 1.603.541 325.768 568.083
General administrative expenses (-) (348.198) (394.626) (100.768) (113.962)
Marketing expenses (-) (455.548) (570.728) (149.521) (224.938)
Research and development expenses (-) (11.604) (13.595) (3.136) (4.434)
Other income from operating activities 17 15.883 20.960 3.515 4.109
Other expenses from operating activities (-) 17 (10.235) (32.183) (1.470) (12.934)
Operating profit / (loss) (39.467) 613.369 74.388 215.924
Income from investment activities 18 212 716 142 38
Expens from investment activities (-) 18 (3.132) (57.826) (1.551) 10.629
Operating profit before finance income / (expense) (42.387) 556.259 72.979 226.591
Finance income 19 84.178 257.621 1.369 (18.185)
Finance expenses (-) 19 (515.796) (559.611) (197.527) (127.472)
Monetary gain / (loss) 25 171.724 149.895 68.070 53.964
Profit/(Loss) before tax from continuing operations (302.281) 404.164 (55.109) 134.898
Tax income from continuing operations 96.005 (136.144) 25.773 (83.121)
- Taxes on expense 20 - (183.057) - (117.542)
- Deferred tax income / (expense) 20 96.005 46.913 25.773 34.421
Net profit /(loss) for the year (206.276) 268.020 (29.336) 51.777
Profit /(loss) per share (1 TRL per share) 21 (0,7938) 8,3033 (0,1129) 1,6041

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF OTHER COMPREHENSIVE INCOME FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

Unaudited Unaudited
1 January - 1 January - 1 July - 1 July -
Notes 30 September 2025 30 September 2024 30 September 2025 30 September 2024
Net profit /(loss) for the year (206.276) 268.020 (29.336) 51.777
Other comprehensive income/expense
Other comprehensive expenses that will not be reclassified to profit or loss (6.642) 8.983 (1.441) (1.349)
- Gains (Losses) on Remeasurements Defined Benefit Plans 13 (8.852) 11.980 (1.863) (1.796)
Other comprehensive expenses that will not be reclassified to profit or loss, tax effect 2.210 (2.997) 422 447
- Deferred tax income / (expense) 2.210 (2.997) 422 447
Other comprehensive income / (expense) that will be reclassified to profit or loss (428) (2.154) (109) (2.387)
- Currency translation differences
- Other comprehensive income / (expense) on cash flow hedge
-Other Comprehensive income / (expense) on cash flow hedge (571) (2.870) (145) (3.180)
-Other comprehensive expenses that will be reclassified to profit or loss, tax effect 143 716 36 793
- Deferred tax income / (expense) 143 716 36 793
Other comprehensive income / (expense) (7.070) 6.829 (1.550) (3.736)
Total comprehensive income (213.346) 274.849 (30.886) 48.041

CONVENIENCE TRANSLATION INTO ENGLISH OF INTERIM FINANCIAL STATEMENTS ORIGINALLY ISSUED IN TURKISH ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF CHANGES IN EQUITY FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

Other comprehensive income (loss) that Other co omprehensive
will not be reclassified
in profit or loss
loss/(income
reclassified in
e) that will be Accumulat ad puofita
-
Inflation
Defined benefit plans Currency pront or loss Accumulat eu pronts
adjustment to revaluation and translation G Sains/(loss) on Restricted Retained Net profit/(loss)
Share capital share capital measurement(losses)/gains differences he dge reserves earnings for the period Total equity
Balances as of 1 January 2024 23.625 700.249 (25.079) (7.131) 17.699 357.565 155.208 789.504 2.011.640
Liquidation effect - - - 7.131 - - - - 7.131
Transfers 236.250 (236.250) - - - 20.346 769.158 (789.504) -
Subsidiary acquisition or disposal - - - - - - (228.800) - (228.800)
Total comprehensive income / (loss) - - 8.983 - (2.154) - - 268.020 274.849
Balances as of 30 September 2024 259.875 463.999 (16.096) 15.545 377.911 695.566 268.020 2.064.820
Balances as of 1 January 2025 259.875 464.004 (18.794) - 15.639 377.967 695.513 23.385 1.817.589
Transfers - - - - - 10.288 13.097 (23.385) -
Subsidiary acquisition or disposal - - - - - - (165.998) - (165.998)
Total comprehensive income / (loss) - - (6.642) - (428) - - (206.276) (213.346)
Balances as of 30 September 2025 259.875 464.004 (25.436) - 15.211 388.255 542.612 (206.276) 1.438.245

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF CASH FLOWS FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

Notes
Cash flow from operating activities
Net profit /(loss) for the period
Adjustments to reconcile net profit /(loss) for the period
Adjustments for depreciation and amortization expense
6,10,11
Adjustments for impairment loss/(reversal)
- Adjustments for impairment / (reversal) of receivables
7
Adjustments for provisions
- Adjustments for provisions / (reversal) for employee benefits
13
- Adjustments for provisions / (reversal) for lawsuit and other provisions
12
Adjustments for interest (income) / expense
- Adjustments for interest income
1 9
- Adjustments for interest expense
1 9
- Rediscount on interest income
Adjustments for fair value (gain) / loss
Adjustments for tax incomes
20
Adjustments for gain / (loss) on sale of tangible and intangible assets
Monetary gain / (loss)
Changes in working capital
Adjustments for decrease/(increase) in trade receivables
Adjustments for decrease/(increase) in other receivables
Adjustments for decrease/(increase) in inventory
Decrease/(increase) in prepaid expenses
Adjustments for increase/(decrease) in trade payables
Adjustments for increase/(decrease) in employee benefit obligations
Adjustments for increase/(decrease) in other payables from operations
Increase / (decrease) in deferred income (other than obligations
arising from customer contracts)
Adjustments for other increase/(decrease) in working capital
- Increase/(decrease) in other operating assets
- Increase/(decrease) in other operating liabilities
Cash flows from (used in) operating activities
Payments related with provisions for employee benefits
13
Income taxes (paid) return
Cash flow from investing activities
Cash inflows arising from sale of tangible and intangible assets
10
Cash outflows arising from purchase of tangible and intangible assets
10
Cash flow from financing activities
Proceeds from borrowings
6
1 January -
1 January -
30 September 2025 30 September 2024
(1.056.110)
(206.276)
(863.480)
268.020
389.811 480.203
142.180 156.514
1.352 993
1.352 993
32.635 107.390
32.635 103.296
- 4.094
473.632 353.993
(41.415)
515.047
(200.272)
554.718
- (453)
(1.127) (2.497)
136.144
(96.005)
2.920
587
(165.776) (272.921)
(1.294.136) (1.283.322)
(1.121.034)
379
(1.542.280)
10.790
(133.187) 162.777
(6.766) (47.761)
3.172 16.451
(79.787) (50.052)
5.091 8.447
(65.241) (270.957)
103.237 429.263
134.627 363.822
(31.390) 65.441
(1.110.601) (535.099)
(48.509) (29.920)
103.000 (298.461)
(61.202) (43.286)
7.691 3.484
(68.893) (46.770)
429.645 193.250
1.700.000 1.950.555
Repayment of borrowings
6
(525.000) (1.408.003)
Repayment of lease liabilities (42.179) (6.069)
Dividends paid (165.998) (228.800)
Interest paid
6
(576.720) (530.101)
Interest received 38.164 200.542
Other cash inflows (outflows) 1.378 215.126
Monetary gain/(loss) impact on cash and cash equivalents (89.872) (262.278)
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
4
(777.539)
825.977
(975.794)
1.416.231
Cash and cash equivalents at the end of the year
4
48.438 440.437

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 1 – COMPANY'S ORGANIZATON AND NATURE OF OPERATIONS

Adel Kalemcilik Ticaret ve Sanayi A.Ş. ("the Company") 's fields of activity are the production of wooden wall pencils, colored pencils, toy products and other stationery products, sale of hygiene products, the sale and export of the products manufactured in the facilities and importing purchasing and selling of all kinds of raw, semi-finished and finished products.

The company was established on 17 July 1967 and registered with the Istanbul Chamber of Industry (ICI) and the Istanbul Chamber of Commerce (ICOC) on the same date with the registration number 96078.

The registered address of the company's headquarters is as follows:

Fatih Sultan Mehmet Dist. Balkan St. No:58 Buyaka E Block 34771 Tepeüstü - Ümraniye/İstanbul

The Company is registered to the Capital Markets Board ("CMB") and its shares have been traded on Borsa Istanbul ("BIST") since 1996. As of 30 September , the Company has 27.71% of its shares registered in the BIST. The shareholders holding the majority of the Company's shares and their share ratios are as follows:

List of Shareholders

30 September 2025 31 December 2024
% TRL % TRL
AG Anadolu Grubu Holding A.Ş. 56,89 147.831 56,89 147.831
Faber-Castell Aktiengesellschaft 15,40 40.017 15,40 40.017
Shares publicly held 27,71 72.027 27,71 72.027
259.875 259.875

The average number of employees of the Company as at 30 September 2025 is 312 (31 December 2024:371).

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS

2.1 Basis of preparation and presentation of financial statements

2.1.1 Statement of compliance with TFRS

The accompanying financial statements are prepared in accordance with the requirements of Capital Markets Board ("CMB") Communiqué Serial II, No: 14.1 "Basis of Financial Reporting in Capital Markets", which was published in the Official Gazette No:28676 on June 13, 2013. The accompanying financial statements are prepared based on the Turkish Accounting Standards and interpretations ("TAS") issued by the Public Oversight Accounting and Auditing Standards Authority ("POA") under Article 5 of the Communiqué. It is also presented in accordance with the 2025 TFRS Taxonomy updated by POA on July 3, 2024.

The Company's companies operating in Türkiye maintain their books of account and prepare their statutory financial statements in Turkish Lira in accordance with the principles and requirements issued by the Capital Markets Board ("CMB"), the Turkish Commercial Code ("TCC") and Tax Legislation and the Uniform Chart of Accounts issued by the Ministry of Finance.

In accordance with TAS 34 "Interim Financial Reporting", entities are free to prepare their interim financial statements as a full set or condensed. In this context, the Company has preferred to prepare condensed interim financial statements. The condensed interim financial statements and notes are presented including the information required by the CMB.

The interim condensed financial statements should be read in conjunction with the audited financial statements and the accompanying notes as of December 31, 2024.

The financial statements of the Company as of September 30, 2025 were approved by the Board of Directors of the Company on September 30, 2025. The General Assembly is authorized to amend the financial statements.

2.1.2 Adjustment of financial statements in hyperinflationary periods

The Company prepared its financial statements as at and for the period ended September 30, 2025 by applying TAS 29 "Financial Reporting in Hyperinflationary Economies" in accordance with the announcement made by POA on 23 November 2023 and the "Implementation Guide on Financial Reporting in High Inflation Economies". The standard requires that financial statements prepared in the currency of a hyperinflationary economy be expressed in terms of the purchasing power of that currency at the balance sheet date and that comparative figures for prior period financial statements be expressed in terms of the measuring unit current at the end of the reporting period. Accordingly, the Company has also presented its financial statements as of 31 December 2025 in terms of the purchasing power of that currency as of 30 September 2025.

In accordance with the CMB's decision dated 28 December 2023 and numbered 81/1820, it has been decided that issuers and capital market institutions subject to financial reporting regulations applying Turkish Accounting/Financial Reporting Standards will apply inflation accounting in accordance with TAS 29 standards, starting from their annual financial reports for the accounting periods ending as of 31 December 2023.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.1 Basis of preparation and presentation of financial statements (Continued)

2.1.2 Adjustment of financial statements in hyperinflationary periods (Continued)

The restatements in accordance with TAS 29 have been made using the adjustment factor derived from the Consumer Price Index ("CPI") in Türkiye published by the Turkish Statistical Institute ("TSI"). As of September 30, 2025, the indexes and adjustment factors used in the restatement of the financial statements are as follows:

Date Index Adjustment
Coefficient
Three-Year Compound
Inflation Rate
30 September 2025 3.367,22 1,00000 %222
31 December 2024 2.684,55 1,25430 %291
30 September 2024 2.526,16 1,33294 %343

The main elements of the Company's adjustment for financial reporting purposes in high-inflation economies are as follows:

  • The current period financial statements prepared in TRL are expressed with the purchasing power at the balance sheet date, and the amounts from previous reporting periods are also expressed by adjusting according to the purchasing power at the end of the reporting period.
  • Monetary assets and liabilities are not adjusted as they are currently expressed with current purchasing power at the balance sheet date. In cases where the inflation-adjusted values of nonmonetary items exceed the recoverable amount or net realizable value, the provisions of TAS 36 and TAS 2 were applied, respectively.
  • Non-monetary assets and liabilities and equity items that are not expressed in current purchasing power at the balance sheet date have been corrected using the relevant correction coefficients.
  • All items included in the comprehensive income statement, except those that affect the statement of comprehensive income of non-monetary items in the balance sheet, are indexed with coefficients calculated over the periods when the income and expense accounts are first reflected in the financial statements.
  • The effect of inflation on the Company's net monetary asset position in the current period is recorded in the net monetary gain / loss account in the income statement.

2.1.3 Functional and reporting currency

The Company is based on the Turkish Commercial Code ("TCC"), tax legislation and the Uniform Chart of Accounts issued by the Ministry of Finance of the Republic of Türkiye in keeping its accounting records and preparing its statutory financial statements. Investments valued by the equity method in foreign countries, have prepared their statutory financial statements in accordance with the laws and regulations applicable in the countries in which they operate. Financial statements of company have been prepared in Turkish lira on the basis of historical cost, excluding financial assets and liabilities that are expressed at their fair values. The financial statements have been prepared by reflecting the necessary adjustments and classifications in order to make the correct presentation in accordance with TMS/TFRS to the legal records prepared on the historical cost basis.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.1 Basis of preparation and presentation of financial statements (Continued)

2.1. 4 Comparative information and restatement of prior period financial statements

Comparative figures are reclassified, where necessary, to conform to changes in presentation in the current period financial statements and significant changes are explained. The financial statements of the Company include comparative financial information to enable the determination of the trends in the financial position and performance. The Company has prepared its financial position statement as of 30 September 2025 with the financial position statement prepared as of 31 December 2024; The profit or loss statement for the period 1 January- 30 September 2025, the profit or loss statement for the 1 January-30 September 2024 accounting period, and the other comprehensive income statement for the 1 January- 30 September 2025 accounting period, the 1 January- 30 September 2024 accounting period, other comprehensive income statement, cash flow statement for the accounting period 1 January-30 September 2025 and statements of changes in shareholders' equity are prepared comparatively with the related financial statements for the accounting period 1 January – 30 September 2024.

The amount of TRL 32.484 shown under "Profit on sale of funds" in "Investment activity income" in the income statement dated September 30, 2024 has been classified under "Profit on sale of funds" in "Finance income."

2.2 New and revised Turkish financial reporting standards

Disclosures regarding the impacts of the new IFRS/TFRS on the financial statements:

  • a) Standards, amendments, and interpretations applicable as of 30 September 2025:
  • Amendments to IAS 21 - Lack of Exchangeability; effective from annual periods beginning on or after 1 January 2025. An entity is impacted by the amendments when it has a transaction or an operation in a foreign currency that is not exchangeable into another currency at a measurement date for a specified purpose. A currency is exchangeable when there is an ability to obtain the other currency (with a normal administrative delay), and the transaction would take place through a market or exchange mechanism that creates enforceable rights and obligations.
  • b) Standards, amendments, and interpretations that are issued but not effective as of 30 September 2025:
  • Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments; effective from annual reporting periods beginning on or after 1 January 2026 (early adoption is available). These amendments:
  • clarify the requirements for the timing of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system;

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.2 New and revised Turkish financial reporting standards (Continued)

b) Standards, amendments, and interpretations that are issued but not effective as of 30 September 2025: (Continued)

  • clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion;
  • add new disclosures for certain instruments with contractual terms that can change cash flows (such as some instruments with features linked to the achievement of environment, social and governance (ESG) targets); and
  • make updates to the disclosures for equity instruments designated at Fair Value through Other Comprehensive Income (FVOCI).
  • Annual improvements to IFRS – Volume 11; effective from annual periods beginning on or after 1 January 2026 (earlier application permitted). Annual improvements are limited to changes that either clarify the wording in an Accounting Standard or correct relatively minor unintended consequences, oversights or conflicts between the requirements in the Accounting Standards. The 2024 amendments are to the following standards:
  • IFRS 1 First-time Adoption of International Financial Reporting Standards;
  • IFRS 7 Financial Instruments: Disclosures and its accompanying Guidance on implementing IFRS 7;
  • IFRS 9 Financial Instruments;
  • IFRS 10 Consolidated Financial Statements; and
  • IAS 7 Statement of Cash Flows.
  • Amendment to IFRS 9 and IFRS 7 - Contracts Referencing Nature-dependent Electricity; effective from annual periods beginning on or after 1 January 2026 but can be early adopted subject to local endorsement where required. These amendments change the 'own use' and hedge accounting requirements of IFRS 9 and include targeted disclosure requirements to IFRS 7. These amendments apply only to contracts that expose an entity to variability in the underlying amount of electricity because the source of its generation depends on uncontrollable natural conditions (such as the weather). These are described as 'contracts referencing nature-dependent electricity'.
  • IFRS 18 Presentation and Disclosure in Financial Statements; effective from annual periods beginning on or after 1 January 2027. This is the new standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss. The key new concepts introduced in IFRS 18 relate to:
  • the structure of the statement of profit or loss;
  • required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity's financial statements (that is, managementdefined performance measures); and
  • enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.2 New and revised Turkish financial reporting standards (Continued)

  • b) Standards, amendments, and interpretations that are issued but not effective as of 30 September 2025: (Continued)
  • IFRS 19 Subsidiaries without Public Accountability: Disclosures; effective from annual periods beginning on or after 1 January 2027. This new standard works alongside other IFRS Accounting Standards. An eligible subsidiary applies the requirements in other IFRS Accounting Standards except for the disclosure requirements and instead applies the reduced disclosure requirements in IFRS 19. IFRS 19's reduced disclosure requirements balance the information needs of the users of eligible subsidiaries' financial statements with cost savings for preparers. IFRS 19 is a voluntary standard for eligible subsidiaries. A subsidiary is eligible if:
    • it does not have public accountability; and
    • it has an ultimate or intermediate parent that produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.

2.3 Changes and errors in accounting estimates

Accounting estimates are made on the basis of reliable information and reasonable estimation methods. However, estimates are revised if there is a change in the circumstances under which the estimate was made, or if new information becomes available, or if additional developments occur. The effect of a change in an accounting estimate is recognized in the current period in which the change is made, if the change affects only one period, or prospectively in both the current and future periods, if the change affects future periods, in the financial statements in a manner that takes into account in determining the profit or loss for the period.

The nature and amount of any change in an accounting estimate that has an effect on the result of operations in the current period or is expected to have an effect on subsequent periods is disclosed in the notes to the financial statements, except where it is not possible to estimate the effect on future periods. As of September 30, 2025, there have been no changes and errors in accounting estimates.

2.4 Seasonality of activities

The Company starts with a sales campaign for certain products at the beginning of the year and then organizes "dealer fairs" in the first quarter of the year to sell the brands it produces and imports. During these sales campaigns and dealer fairs, checks, DDS, credit cards are taken against the order amounts of the customers and most of the shipment of the orders received is realized in the first half of the year.

2.5 Significant accounting judgments, estimates and assumptions

Fair values of derivatives and other financial instruments

The Company calculates the fair values of financial instruments that do not have an active market by using market data, the use of similar transactions without collusion, reference to the fair values of similar instruments and discounted cash flow analysis.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.5 Significant accounting judgments, estimates and assumptions (Continued)

Expected credit losses

Provision for doubtful receivables is accounted for using expected credit losses defined in TFRS 9 standard. Calculated using expected credit losses and excluding dealers subject to the Direct Debit System, taking into account the company's forecasts for the future, in addition to past experience.

NOTE 3 – SEGMENT REPORTING

Fields of activity of the Company established in Türkiye are, respectively, the production of wooden wall pencils, colored pencils, toy products and other stationery equipment, the sale and export of finished products in the facilities, and importing all kinds of raw materials, semi-finished products and finished products, to buy and sell.

The Company's field of activity, the nature and economic characteristics of the products, the production processes, the classification according to the risks of the customers and the methods used in the distribution of the products are similar. In addition, the organizational structure of the Company has been established in such a way that a single activity is managed instead of the Company being managed in separate divisions containing different activities. For these reasons, the Company's operations are considered as a single operating segment, and the Company's operating results, the determination of the resources to be allocated to these activities, and the examination of the performances of these activities are evaluated within this framework.

NOTE 4 – CASH AND CASH EQUIVALENTS

30 September 2025 31 December 2024
Demand deposit 7.960 44.181
Time deposit 37.030 204
Other cash equivalents 3.448 781.592
Cash and cash equivalents in the statement of cash flows 48.438 825.977
Interest income accruals 7 1.027
Total 48.445 827.004

The Company has no blocked deposits as of 30 September 2025 (31 December 2024: None).

NOTE 5 – FINANCIAL INVESTMENTS

30 September 2025
% TRL
31 December 2024
% TRL
Ülkü
Kırtasiye Ticaret ve Sanayi A.Ş.
7,67 113 7,67 113
Other long-term investments (*) 1.451 1.524
1.564 1.637

(*) It is the amount of venture capital investment fund received by our company on a long-term basis, equal to 2% of the corporate tax incentive amount used, as it is an R&D center.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS

30 September 2025 Interest rate % Balance
Short term borrowings
TRL loans 23,47- 47,00 1.043.118
Debt instruments issued (*) TLref + %1 510.247
1.553.365

(*) The Company will sell to qualified investors without public offering debt instruments worth TRL500,000 with a maturity of 364 days, carrying a variable interest rate of 100 basis points linked to the BIST TLREF index, with two coupon payments and redemption dated 13 March 2026.

As of 30 September 2025, the interest accrual calculated for the Company's short-term loans is classified within the relevant short-term bank loans, and the interest accrual calculated for the issued debt instruments is classified within the issued debt instruments.

30 September 2025 Interest rate % Balance
Short-term portions of long-term borrowings
Short-term portions of long-term finance leases - 45.568
Short-term portions of long-term loans TLref + %1 172.674
Short-term portions of long-term issued debt instruments (*) TLref + %1 251.989
470.231

(*) The Company has debt instruments amounting to TRL250,000, with a maturity of 730 days, carrying a variable interest rate of 100 basis points linked to the BIST TLREF index, with four coupon payments, and redemption dated 24 September 2026. These instruments are offered domestically to qualified investors without a public offering.

As of 30 September 2025, the interest accrual calculated for the Company's short-term loans is classified within the relevant short-term bank loans, and the interest accrual calculated for the issued debt instruments is classified within the issued debt instruments.

30 September 2025 Interest rate % Balance
Long term borrowings
Long-term lease payables 66.598
66.598
31 December 2024 Interest rate % Balance
Short term borrowings
TRL loans 48,00 - 54,00 489.275
489.275

As of 31 December 2024, the interest accrual calculated for the short-term loans of the Company has been classified under the related short-term bank loans.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS (Continued)

31 December 2024 Interest rate % Balance
Short-term portions of long-term borrowings
Short-term portions of long-term finance leases - 59.274
Short-term portions of long-term loans TLref + %1 35.083
Short-term portions of long-term issued debt instruments TLref + %1 45.073
139.430

As of December 31, 2024, the accrued interest related to the current portions of long-term borrowings has been classified within the current portions of the respective long-term borrowings.

31 December 2024 Interest rate %
Long term borrowings
TRL loans TLref + %1 213.231
Debt instruments issued (*) TLref + %1 313.575
Long-term lease payables - 108.351
635.157

As of 30 September 2025, and 31 December 2024, the maturity details of the Company's long-term loans and financial lease borrowings are given below.

30 September 2025 Total
liabilities
1-2 years 66.598
66.598
31 December 2024 Total
liabilities
1-2 years 635.157
635.157

The movement of financial borrowings is as follows:

2025 2024
1 January 1.096.237 1.815.014
Cash inflows from borrowing 1.700.000 1.950.555
Cash outflows related to debt payments (525.000) (1.408.003)
Interest expense 482.078 529.262
Interest paid (576.720) (530.101)
Monetary (gain) / loss (198.567) (456.134)
30 September 1.978.028 1.900.593

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS (Continued)

The movement of lease liabilities is as follows:

2025 2024
1 January 167.627 200.007
Cash inflow within the period 17.848 160.009
Cash outflows related to lease payments for the period (60.027) (58.419)
Interest expense 32.969 25.456
Contract amendment (3.609) -
Monetary (gain) / loss (42.642) (107.656)
30 September 112.166 219.397

The movement of the Company's right of use assets as of September 30, 2025 and September 30, 2024 is presented below.

Right of use assets Vehicles Buildings Total
As of 1 January 2025 40.368 151.698 192.066
Additions 17.848 - 17.848
Disposal - (11.709) (11.709)
Changes in contracts - (3.609) (3.609)
Current depreciation expense (*) (23.110) (30.037) (53.147)
As of 30 September 2025 35.106 106.343 141.449

(*) 105 TRL of depreciation expenses is included in the cost of goods sold, 10.851 TRL is included in general administrative expenses and 42.191 TRL is included in marketing, selling and distribution expenses.

Right of use assets Vehicles Buildings Total
As of 1 January 2024 50.665 193.415 244.080
Additions - 160.009 160.009
Disposal (2.629) (159.044) (161.673)
Current depreciation expense (*) (22.452) (38.358) (60.810)
As of 30 September 2024 25.584 156.022 181.606

(*) 356 TRL of depreciation expenses is included in the cost of goods sold, TRL 5.274 is included in general administrative expenses and TRL 55.180 is included in marketing, selling and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 7 – TRADE RECEIVABLES AND PAYABLES

Trade Receivables 30 September 2025 31 December 2024
Trade receivables from related parties (Note 22) 147.725 53.613
Trade receivables from third parties 1.136.529 110.959
1.284.254 164.572
Trade receivables from third parties 30 September 2025 31 December 2024
Cheques and notes receivables 79.485 1.973
Trade receivables 1.065.916 118.345
Provisions for doubtful trade receivables (-) (8.872) (9.359)
1.136.529 110.959

As of 30 September 2025, and 2024, the movement for doubtful trade receivables is as follows:

the movement for doubtful trade receivables is as follows:
2025 2024
9.359 11.551
1.891 993
(539) -
(1.839) (3.077)
8.872 9.467
30 September 2025 31 December 2024
5.357 9.017
164.591 157.758
169.948 166.775
30 September 2025 31 December 2024
164.545 150.046
4 6 7.712
164.591 157.758

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 8 – OTHER RECEIVABLES AND PAYABLES

Other receivables 30 September 2025 31 December 2024
Other receivables from third parties 1.534 1.913
1.534 1.913
Other receivables from third parties 30 September 2025 31 December 2024
Receivables from employees 1 3 1.248
Deposits and guarantees given 332 440
Other miscellaneous receivables 1.189 225
1.534 1.913
Other payables 30 September 2025 31 December 2024
Other payables to third parties 9.894 4.803
9.894 4.803
Other payables to third parties 30 September 2025 31 December 2024
Taxes, fees and deductions payable 9.136 3.954
Other 758
9.894
849
4.803
Employee benefit obligations 30 September 2025 31 December 2024
Payables to employees 34.853 78.448
Social security premiums payable 11.719 11.725
Taxes, fees and deductions payable 10.530 45.447
57.102 135.620
Long-term employee benefit obligations 30 September 2025 31 December 2024
Payables to employees 1.635 2.904
1.635 2.904

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 9 – INVENTORIES

30 September 2025 31 December 2024
Raw materials 276.114 263.838
Semi-finished goods 107.690 127.775
Finished goods 367.081 334.713
Trade goods 390.708 281.028
Other inventories 13.336 14.388
Provision for impairment of inventories (-) (*) (31.555) (31.555)
1.123.374 990.187

(*) As of 30 September 2025 and 2024, the movement table for the provision for inventory impairment, as a result of the assessment of the recoverability of inventories, is as follows:

2025 2024
As of 1 January 31.555 29.621
Provisions no longer required (-) - -
30 September 31.555 29.621

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 10 - PROPERTY, PLANT AND EQUIPMENT

Lands Land improvements and buildings Buildings Machinery and equipment Vehicles Furniture and fixtures Construction in progress Special Cost Total
As of 1 January 2025, _
Cost 54.370 25.758 849.555 1.186.101 19.005 322.852 32.999 5.731 2.496.371
Accumulated depreciation - (23.666) (175.140) (995.954) (18.975) (287.515) - (4.359) (1.505.609)
Net book value 54.370 2.092 674.415 190.147 30 35.337 32.999 1.372 990.762
Opening balance 54.370 2.092 674.415 190.147 30 35.337 32.999 1.372 990.762
Additions - - 650 12.622 _ 4.471 27.015 - 44.758
Disposal cost - - - (23.097) - (50.972) (3.480) (3.681) (81.230)
Disposal depreciation - - - 23.004 - 47.058 - 3.665 73.727
Transfers - - 266 1.738 - - (17.720) - (15.716)
Depreciation (*) - (262) (14.171) (36.861) (16) (8.309) - (297) (59.916)
Closing balance 54.370 1.830 661.160 167.553 14 27.585 38.814 1.059 952.385
As of 30 September 2025,
Cost 54.370 25.758 850.471 1.177.364 19.005 276.351 38.814 2.050 2.444.183
Accumulated depreciation - (23.928) (189.311) (1.009.811) (18.991) (248.766) _ (991) (1.491.798)
Net book value 54.370 1.830 661.160 167.553 14 27.585 38.814 1.059 952.385

(*) 47.716 TRL of depreciation expenses is included in the cost of goods sold, 2.155 TRL is included in general administrative expenses, 2.469 TRL is included in research and development expenses, and 7.576 TRL is included in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 11 – PROPERTY, PLANT AND EQUIPMENT (Continued)

Lands Land
improvements
and buildings
Buildings Machinery and equipment Vehicles Furniture and C Construction in progress Special Cost Total
As of 1 January 2024,
Cost 54.369 25.758 847.011 1.171.534 19.005 317.236 - 6.555 2.441.468
Accumulated depreciation - (23.312) (154.704) (951.877) (18.959) (280.894) - (2.683) (1.432.429)
Net book value 54.369 2.446 692.307 219.657 46 36.342 - 3.872 1.009.039
Opening balance 54.369 2.446 692.307 219.657 46 36.342 - 3.872 1.009.039
Additions - - 416 6.183 - 6.721 32.153 - 45.473
Disposal cost - - - (955) - (6.990) _ - (7.945)
Disposal depreciation - - - 528 - 4.039 - - 4.567
Depreciation (*) (15.716) (33.497) (10) (9.011) (2.204) (60.438)
Closing balance 54.369 2.446 677.007 191.916 36 31.101 32.153 1.668 990.696
As of 30 September 2024,
Cost 54.369 25.758 847.427 1.176.762 19.005 316.967 32.153 6.555 2.478.996
Accumulated depreciation (23.312) (170.420) (984.846) (18.969) (285.866) - (4.887) (1.488.300)
Net book value 54.369 2.446 677.007 191.916 36 31.101 32.153 1.668 990.696

(*) 44.479 TRL of depreciation expenses is included in the cost of goods sold, 1.638 TRL is included in general administrative expenses, 2.418 TRL is included in research and development expenses, and 11.903 TRL is included in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 11 – INTANGIBLE ASSETS

Intangible assets include computer software, rights and development costs.

License License Other intangible
Rights Developments agreements assets Total
As of 1 January 2025,
Cost 4.025 110.130 299.349 25.492 438.996
Accumulated amortizations (3.756) (38.766) (259.577) (25.629) (327.728)
Net book value 269 71.364 39.772 (137) 111.268
Opening balance 269 71.364 39.772 (137) 111.268
Additions - 20.394 - 821 21.215
Disposal cost (1.703) - - - (1.703)
Disposal depreciation 1.515 - - - 1.515
Transfers - 15.716 - - 15.716
Depreciation (*) - (17.403) (11.714) - (29.117)
End of the period 81 90.071 28.058 684 118.894
As of 30 September 2025,
Cost 2.322 146.240 299.349 26.313 474.224
Accumulated amortizations (2.241) (56.169) (271.291) (25.629) (355.330)
Net book value 81 90.071 28.058 684 118.894

(*) For the current period, 18.101 TRL of amortization is included in the cost of goods sold, 1.930 TRL is included in the cost of general administrative expenses, 5.162 TRL is included in the cost of research and development expenses, and 3.924 TRL is included in the cost of marketing, sales and distribution expenses.

Rights Developments License agreements Other intangible assets Total
As of 1 January 2024,
Cost 4.025 108.077 287.325 23.740 423.167
Accumulated amortizations (3.539) (17.116) (239.972) (19.482) (280.109)
Net book value 486 90.961 47.353 4.258 143.058
Opening balance 486 90.961 47.353 4.258 143.058
Additions - - 628 - 628
Depreciation (*) (169) (16.303) (15.538) (3.256) (35.266)
End of the period 317 74.658 32.443 1.002 108.420
As of 30 September 2024,
Cost 4.025 108.077 287.953 23.740 423.795
Accumulated amortizations (3.708) (33.419) (255.510) (22.738) (315.375)
Net book value 317 74.658 32.443 1.002 108.420

(*) For the current period, TRL 19.056 of amortization is included in the cost of goods sold, TRL 1.456 is included in the cost of general administrative expenses, TRL 4.801 is included in the cost of research and development expenses, and TRL 9.953 is included in the cost of marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES

30 September 2025 31 December 2024

Provisions for lawsuits 5.259 6.592
5.259 6.592

The Company's 15 employees have filed 15 lawsuits against the Company for the cancellation of the termination of their employment contracts, reemployment and other compensation claims and a litigation provision amounting to TRL 5.259 has been set aside as a result of the evaluations of the lawyers in relation to the related lawsuits.

2025 2024
As of 1 January, 6.591 338
Provision provided during the period - 4.094
Monetary (gain) / loss (1.332) (89)
As of 30 September , 5.259 4.343

Contingent liabilities and contingent assets

After Adel Kalemcilik Ticaret ve Sanayi A.Ş. could not collect its receivable of 60 TRL arising from its current account relationship with its customer, Istanbul 18th Enforcement Directorate file number 2012/20785E and 2012/18797E and Kartal 1st Enforcement Directorate file number 2012/6142E. Enforcement proceedings were carried out with and the sale of the seized real estate was requested on 7 October 2013. The valuation report has been notified and the real estate sales process continues.

2014/14137E, 2014/15246E, 2014/16896E, filed under Izmir 2, 8, 10 and 14th Enforcement Directorate, as a result Adel Kalemcilik Ticaret ve Sanayi A.Ş.'s inability to collect its receivable of 594 TRL arising from its current account relationship with its customer and 2015/574E, enforcement proceedings were initiated against the debtor company, and a payment order notification was issued against the debtor company, by proceeding with the main proceeding through a lien specific to bills of exchange. Investigations continue for the purpose of collecting the receivable.

There are commercial lawsuits filed against Adel Kalemcilik Ticaret ve Sanayi A.Ş. by the employees of the two subcontractors, whose contracts the Company terminated as of 31 August 2013, due to their failure to fulfill their legal obligations towards their employees, within the framework of the principles of joint and several liability. Provision has been made as of 30 September 2025. The company has objected to the enforcement proceedings in question and the proceedings are continuing.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES (Continued)

Contingent liabilities and contingent assets (Continued)

Following the failure of Adel Kalemcilik Ticaret ve Sanayi A.Ş. to collect its receivables arising from its current account relationship with its customer, a lawsuit was filed with the file number 2016/12354 E (New Basis: 2021/14645 E.) filed within the Istanbul Anatolian 17th Enforcement Directorate. Provision has been made for the amount. Main proceedings have been initiated and the assets recorded on the debtor have been inquired about. There are no assets registered in the name of the debtor, investigations are continuing to collect the receivable.

Following the inability of Adel Kalemcilik Ticaret ve Sanayi A.Ş. to collect due to its current account relationship with its customer, a receivable was recorded in the bankruptcy estate with the file number 2017/32 at Istanbul Anadolu 3rd Bankruptcy Directorate. A provision has been made for the said amount.

Due to the Company's inability to collect a receivable of TRL495 arising from an advance payment relationship with its supplier, a legal follow-up has been initiated under file number 2024/25778 at the Gebze Enforcement Office, and a provision has been recognized for the related amount. The main enforcement proceeding has commenced, and investigations have been conducted to identify assets registered under the debtor's name. No assets have been found registered under the debtor. Efforts to collect the receivable are ongoing.

These proceedings are not expected to have a material impact on the Company's operating results, financial position, or liquidity.

Deposits and guarantees given30 September 202531 December 2024Letters of guarantee68.98420.281Letter of credit commitments-48.418

As of 30 September 2025, and 31 December 2024, the tables regarding the Company's collateral/pledge/mortgage ("CPM") position are as follows:

30 September 2025

Letter of guarantees, pledge and mortgages provided by the Company TRL equivalents EUR TRL
A. Total amount of GPMs given on behalf of the Company's legal personality 68.984 - 68.984
B. Total amount of GPMs given in favor of subsidiaries included in full consolidation - - -
Total amount of GPMs given by the Company for the liabilities of 3rd parties
C. in - - -
order to run ordinary course of business
D. Total amount of other GPM's - - -
i. Total amount of GPMs given in favor of the parent Company - - -
ii. Total amount of GPMs given in favor of other group companies not in the _
scope - -
of B and C above
iii. Total amount of GPMs given in favor of third party companies not in the
scope of C above -
68.984 - 68.984

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES (Continued)

31 December 2024

Letter of guarantees, pledge and mortgages provided by the Company TRL equivalents EUR TRL
A. Total amount of GPMs given on behalf of the Company's legal personality 20.281 - 20.281
B. Total amount of GPMs given in favor of subsidiaries included in full consolidation - - -
C. Total amount of GPMs given by the Company for the liabilities of 3rd parties in - - -
order to run ordinary course of business D. Total amount of other GPM's - _ _
i. Total amount of GPMs given in favor of the parent Company - - -
ii. Total amount of GPMs given in favor of other group companies not in the scope of B and C above - - -
iii. Total amount of GPMs given in favor of third party companies not in the scope of C above - - -
20.281 - 20.281

The ratio of other CPMs given by the company to the equity of the Company is 0% as of 30 September 2025 (31 December 2024: 0%).

NOTE 13 – EMPLOYEE BENEFITS

Short term employee benefits 30 September 2025 31 December 2024
Premium accruals - 14.290
Provisions for unused vacations 4.156 2.972
4.156 17.262
Long term employee benefits 30 September 2025 31 December 2024
Provisons for employment termination benefits 36.714 41.895
36.714 41.895

The movement table of unused vacation accruals as of 30 September 2025 and 2024 is as follows:

2025 2024
As of 1 January, 2.972 4.664
Addition 18.542 10.884
Provision for vacation used (15.613) (11.572)
Monetary (gain) / loss (1.745) (1.230)
30 September 4.156 2.746

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 13 – EMPLOYEE BENEFITS (Continued)

Provisions for employee termination benefits

In accordance with the provisions of the Labor Law in force, there is an obligation to pay the legal severance pay to employees whose employment contract has ended so that they are entitled to severance pay.

In addition, in accordance with the legislation currently in force, there is an obligation to pay the legal severance pay to those who have the right to leave the job by receiving severance pay. As of 1 July 2025, the severance pay to be paid is subject to a monthly ceiling of 53,919,68 full TRL (1 January 2025: 46,655,43 TRL). Severance pay liability is not legally subject to any funding. Severance pay liability is calculated based on the estimation of the present value of the company's possible future liability arising from the retirement of employees. TAS 19 ("Employee Benefits") requires the company to develop its liabilities within the scope of defined monthly plans using actuarial valuation methods. Accordingly, the actuarial assumptions used in calculating total liabilities are stated below:

The main assumption is that the maximum liability amount for each year of service will increase in line with inflation. Therefore, the discount rate applied represents the expected real rate after adjusting for the effects of future inflation. Therefore, the provisions in the accompanying financial statements as of 30 September 2025 and 31 December 2024 are calculated by estimating the present value of the future probable obligation arising from the retirement of the employees.

Severance Pay Accrual Movement Table
2025 2024
As of 1 January 41.895 52.318
Service cost 14.093 19.155
Severance pay paid (18.606) (7.839)
Actuarial (gain) / loss 8.852 (11.980)
Monetary (gain) / loss (9.520) (9.550)
30 September 36.714 42.104
30 September 2025 31 December 2024
Discount rate (%) 2,58 2,58
Turnover rate used in retirement probability calculation (%) 92,64 92,82

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 14 – OTHER ASSETS AND LIABILITIES

Short-term prepaid expenses 30 September 2025 31 December 2024
Advances given 9.749 17.047
Prepaid expenses for the coming months 11.918 5.685
21.667 22.732
Current tax assets 30 September 2025 31 December 2024
Prepaid taxes and funds 5.771 152.651
5.771 152.651
Other current assets 30 September 2025 31 December 2024
Deffered VAT 28.110 88.990
Other miscellaneous current assets 128 8 2
28.238 89.072
Long-term prepaid expenses 30 September 2025 31 December 2024
Prepaid expense for the following years 28.606 20.774
28.606 20.774
Deffered income 30 September 2025 31 December 2024
Advances received 11.338 76.579
11.338 76.579

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 15 – CAPITAL, RESERVES AND OTHER EQUITY ITEMS

Equity

The shareholders of the Company and their shares in the capital are given below.

30 September 2025 31 December 2024
% Share Balance % Share Balance
AG Anadolu Grubu Holding A.Ş. 56,89 147.831 56,89 147.831
Faber - Castell Aktiengesellschaft 15,40 40.017 15,40 40.017
Shares publicly held 27,71 72.027 27,71 72.027
Paid in capital 100,00 259.875 100,00 259.875
Inflation adjustment to share capital 464.004 464.004
Total capital 723.879 723.879

Inflation adjustments to share capital represent the effect of restating cash additions to paid-in capital with year-end purchasing power.

Number of shares and share groups and privileges:

40.017.351 shares of the Company, amounting to TRL 40.017 are registered in the name of the holder and 219.857.649 shares, amounting to TRL 219.858 are bearer share certificates in accordance with the Foreign Capital Legislation. There are no privileges granted to shareholders in the election of the Board of Directors.

Restricted reserves

The legal reserves consist of first and second legal reserves in accordance with the TCC. The first legal reserve is appropriated out of the statutory profits at the rate of 5%, until the total reserve reaches a maximum of 20% of the Company's restated share capital. The second legal reserve is appropriated at the rate of 10% of all distributions in excess of 5% of the Company's restated share capital. Under TCC, the legal reserves are only available for netting off losses unless they exceed 50% of the historical paidin share capital otherwise they are not allowed to be used for other purposes. As a result of the sale of the immovable and participation shares evaluated within the scope of Article 5/e of the Corporate Tax Law No. 5520, 75% of the sales profit has been classified as "Profit from the sale of real estate and participation shares".

30 September 2025 31 December 2024

388.255 377.967
R&D investment fund 1.979 1.979
Gain on sale of real estate and associate shares 1.831 5.280
Legal reserves 384.445 370.708

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 15 – CAPITAL, RESERVES AND OTHER EQUITY ITEMS (Continued)

Retained Earnings

Retained earnings consist of extraordinary reserves and other retained earnings. Publicly listed companies distribute dividends in accordance with the requirements of CMB as explained below:

30 September 2025 31 December 2024
------------------------------------ -- --
542.612 695.513
Extraordinary reserves 235.861 272.501
Other retained earnigs /(losses) 306.751 423.012

As of September 30, 2025 and 2024, the fund items included within equity in the financial statements prepared in accordance with the Tax Procedure Law are as follows:

30 September 2025
CPI Adjusted PPI Adjusted Followed
Retained Earnings Statuary Entrys Statuary Entrys ammount of
Adjustments to share capital 584.583 464.004 120.579
Reserves on retained erning 417.211 388.255 28.956

Dividend distribution

In accordance with the CMB decision numbered 7/242 dated 25 February 2005; If the profit distribution amount calculated in accordance with the CMB's regulations regarding the minimum profit distribution obligation, based on the net distributable profit found in accordance with the CMB regulations, can be fully covered from the distributable profit in the legal records, this entire amount will be distributed, and if not, the entire net distributable profit in the legal records will be distributed. If there is a period loss in the financial statements prepared in accordance with CMB regulations or in any of the legal records, no profit distribution will be made. With the decision of the CMB dated 27 January 2010, it was decided not to impose any minimum profit distribution obligation on dividend distribution for publicly held joint stock companies whose shares are traded on the stock exchange.

Capital increase, free of charge, capital inflation adjustment differences and registered values of extraordinary reserves; It can be used for cash profit distribution or loss offset. However, equity inflation adjustment differences are subject to corporate tax if used in cash profit distribution.

The company management took the profit distribution decision at the General Assembly meeting. In case of distribution of these profits, the entire profit distribution amount will be covered from the distributable profit in the legal records.

At the Ordinary General Assembly meeting held on April 16, 2025, it was decided to distribute a net period profit of 150.026 full TRL as a dividend from the Company's 2024 operating year according to the Profit Distribution Table prepared within the scope of the Capital Markets Board Dividend Guide. It was decided to distribute the gross dividend to full taxpayer institutions at a rate of 57,73%, which is 0,5773 full TRL for each share with a nominal value of 1 full TRL, and at a net rate of 49,07%, which is 0,4907 full TRL for each share with a nominal value of 1 full TRL. Dividend payments were made on September 26, 2025.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 16 - REVENUE AND COST OF SALES

1 January -
30 September 2025
1 January -
30 September 2024
1 July -
30 September 2025
1 July -
30 September 2024
Domestic sales 2.550.325 4.444.254 1.072.799 1.758.436
Export sales 113.907 127.271 49.511 44.501
Sales discounts (-) (821.805) (1.451.755) (310.427) (543.155)
Net sales 1.842.427 3.119.770 811.883 1.259.782
Cost of sales (-) (1.072.192) (1.516.229) (486.115) (691.699)
Gross profit 770.235 1.603.541 325.768 568.083

The breakdown of the cost of sales by periods is as follows:

1 January -
30 September 2025
1 January -
30 September 2024
1 July -
30 September 2025
Direct material cost 260.842 373.219 105.876 128.629
Direct labour costs 209.371 228.904 57.954 70.019
General production expenses 84.931 108.978 25.245 37.418
Depreciation and amortization expenses 66.254 63.890 23.989 24.655
Provision for impairment of inventories - - - -
Change in semi-finished goods 20.085 11.632 35.195 45.735
Change in finished goods (32.366) 133.576 15.641 134.311
Cost of products sold 609.117 920.199 263.900 440.767
Cost of goods sold 463.075 596.030 222.215 250.932
Cost of sales 1.072.192 1.516.229 486.115 691.699

NOTE 17 – OTHER INCOME AND EXPENSES FROM OPERATING ACTIVITIES

1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Other income from operating activities
Foreign exchange gain 12.008 14.320 1.642 3.663
Insurance indemnity income 143 337 (18) (16)
Reversal of provision for doubtful trade receivables (Note 7) 539 - - -
Other 3.193 6.303 1.891 462
15.883 20,960 3.515 4.109
1 January - 1 January - 1 July - 1 Tl
30 September 2025 30 September 2025
Other expenses from operating activities 30 September 2024 30 September 2025 30 September 2024
Other expenses from operating activities Foreign exchange losses 30 September 2025
6.368
30 September 2024 30 September 2025 30 September 2024
30 September 2024 30 September 2025
925
30 September 2024
Foreign exchange losses 6.368 30 September 2024
7.873
30 September 2025 30 September 2024
Foreign exchange losses
Provision for doubtful trade receivables (Note 7)
6.368 7.873
993
4.420
30 September 2025
925
30 September 2024 1.352 (24)
Foreign exchange losses Provision for doubtful trade receivables (Note 7) Litigation provision expenses (Note 12) 6.368
1.891
7.873
993
4.420
10.393
30 September 2025
925
-
-
15
30 September 2024 1.352 (24) 2.024 7.706

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 18 – INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES

1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Income from investment activities
Gain on sale of property, plant and equipment 212 716 142 3 8
212 716 142 3 8
1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Expense from investment activities
Expense arising from the cancellation of the lease agreement 3.132 50.700 1.551 (10.629)
Transfer of foreign currency translation
differences previously recognized in other comprehensive income to the
statement
- 7.126 - -
of income
3.132 57.826 1.551 (10.629)

NOTE 19 – FINANCE INCOME AND EXPENSES

1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Finance income
Interest income 41.415 178.703 6.572 2.227
Gain on sale of funds 38.492 32.484 - 11.407
Foreign exchange income 4.271 24.865 (5.203) (33.954)
Currency-protected deposit income - 21.390 - 2.152
Interest income from sublease receivables - 179 - (17)
84.178 257.621 1.369 (18.185)
1 January - 1 January - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
1 July -
Finance expenses
Interest expenses 515.047 554.718 203.228 163.959
Foreign exchange losses 749 4.893 (5.701) (36.487)
515.796 559.611 197.527 127.472

NOTE 20- DEFERRED TAX ASSETS AND LIABILITIES

The company is subject to taxation in accordance with the tax laws of the countries in which it operates and other legislation.

In Türkiye, the corporate tax rate is 25%. Corporate tax is declared until the twenty-fifth day of the fourth month following the end of the accounting period to which it relates and paid in one lump sum until the end of the relevant month. In accordance with the tax legislation, provisional tax is calculated and paid at the corporate tax rate on quarterly earnings, and the amounts paid in this way are deducted from the tax calculated over the annual income.

Under Turkish tax legislation, tax losses can be carried forward for a maximum of five years following the year in which they were incurred. In addition, tax returns and related accounting records can be examined by the tax administration within five years.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 20- DEFERRED TAX ASSETS AND LIABILITIES (Continued)

1 January - 1 January - 1 July - 1 July -
30 September 202530 September 2024 30 September 202530 September 2024
Current period statutory tax provision (-) - (183.057) - (117.542)
Deferred tax income/(expense) 96.005 46.913 25.773 34.421
Total deferred tax income, net 96.005 (136.144) 25.773 (83.121)

The reconciliation of the period's tax expense with the profit for the period is as follows:

30 September 2025 31 December 2024
Period income tax provision - -
Prepaid tax expenses (-) 5.771 152.651
Profit for the period tax (liability)/receivable, net 5.771 152.651

Tax Advantages Obtained Under the Investment Incentive System:

The Company's earnings from investments subject to incentive certificates are subject to corporate tax at reduced rates from the accounting period in which the investment starts to be operated partially or fully until the investment contribution amount is reached.

Within the scope of the Company's incentive certificates, there is no discounted corporate tax advantage used in return for the current period's legal tax. (30 September 2024: None.)

As of September 30, 2025, the Company has not utilized the R&D tax credit advantage in lieu of legal tax (September 30, 2024: TL 5.496). The tax benefit of TL 14.783 (December 31, 2024: none) that the Company is expected to benefit from in the foreseeable future on the unused R&D deduction is recognized as a deferred tax asset in the financial statements. The income statement for the period January 1 – September 30, 2025, includes deferred tax income of TL 14.783 related to the aforementioned deferred tax asset.

Deferred tax assets are recognized when it is probable that taxable income will be available in future years. Deferred tax assets are calculated based on tax benefits earned from deductible temporary differences, financial losses, and investment deductions with unlimited life that allow for reduced corporate tax payments. In this context, the Company bases the recognition of deferred tax assets arising from investment incentives in its financial statements on long-term plans and evaluates the recoverability of deferred tax assets related to such investment deductions at each balance sheet date based on business models that include taxable profit forecasts. It is anticipated that the deferred tax assets will be recovered within five years from the balance sheet date.

In the sensitivity analysis conducted as of September 30, 2025, when the inputs in the macroeconomic and sectoral assumptions underlying the business plans were increased/decreased by 10%, there was no change in the five-year recovery periods projected for deferred tax assets related to investment incentives.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 20- DEFERRED TAX ASSETS AND LIABILITIES (Continued)

Tax Advantages Obtained Under the Investment Incentive System: (Continued)

Total temprorary differences Deferred tax
30 September 2025 31 December 2024 30 September 2025 31 December 2024
Tangible and intangible assets (8.376) 13.007 (2.094) 3.252
Provision for employment termination benefits 37.457 38.960 9.364 9.740
Turnover and dealer premium provisions 309.899 - 77.475 -
Royalty expense provision 11.846 5 2.962 1
Worker bonus accruals 11.847 (1.742) 2.962 (435)
R&D discount 59.131 - 14.783 -
Adjustments related to derivative instruments 1.926 (5.272) 482 (1.318)
Provision for doubtful receivables 5.795 6.048 1.449 1.512
Provision for unused vacation 4.156 2.972 1.039 743
Inventory, provision for impairment on inventories (151.112) (172.787) (37.778) (43.197)
Litigation provision 5.255 6.591 1.314 1.648
Promotion materials 2.100 2.419 525 605
Bulk consumption sales return provision 7.973 - 1.993 -
Incentive premium accrual 5.713 14.349 1.428 3.587
Lease services (29.283) (24.440) (7.321) (6.110)
Other adjustments (1.103) (327) (279) (81)
Deferred tax asset/(liability), net 273.224 (120.217) 68.304 (30.053)
2025 2024
As of 1 January (30.054) 43.644
Deferred tax expense/(income) 96.005 46.913
Severance pay accounted under equity effect of remeasurement differences 2.210
(2.997)
Impact of derivative financial instruments 143 716
30 September 68.304 88.276

NOTE 21 – EARNINGS PER SHARE

Earnings per share is calculated by dividing the profit for the period by the weighted average number of shares of the Company during the period. The Company's earnings per share calculation is as follows.

1 January - 1 January -
30 September 2025 30 September 2024
Profit /(loss) for the period (206.276) 268.020
Average number of shares
(weighted average number of shares
with a nominal value of TRL 1 per share) 259.875.000 32.278.846
Earnings per share / (loss) (Full TRL) (0,7938) 8,3033

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS

a) Related Party Balances

Receivables from related parties
30 September 2025 31 December 2024
Migros Ticaret A.Ş. (2) 143.674 37.631
A.W.Faber Castell Peruana SA (2) 1.265 2.396
Aep Anadolu Etap Penkon Gıda ve İçecek
(2)
1.261 -
A.W.Faber-Castell Vertrieb GmbH (2) 105 3.971
Anadolu Sağlık Merkezi Hastanesi A.Ş. (2) - 8.467
Other 1.420 1.148
147.725 53.613
Payable to related parties
30 September 2025 31 December 2024
AEH Sigorta Acentalığı A.Ş. (2) 2.216 -
AG Anadolu Grubu Holding A.Ş. (1) 1.208 8.390
A.W.Faber-Castell Vertrieb GmbH (2) 711 2 2
Other 1.222 605
5.357 9.017
Prepaid expenses to related parties 30 September 2025 31 December 2024
A.W.Faber-Castell Vertrieb GmbH (2) 105 -
A.W.Faber-Castell(Guangzhou) (2) 1 1 -
A.W.Faber Castell (I) 1 -
117 -

1) Shareholders

2) Other companies managed by the shareholders

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS (Continued)

b) Related Party Transactions

1 January - 1 January - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
1 July -
Purchases of goods
A.W.Faber-Castell Vertrieb GmbH (2) 125.638 133.177 67.366 62.811
A.W. Faber-Castell (Guangzhou) Stationery Co. Ltd. (2) 123.296 82.469 87.422 -
A.W.Faber Castell (M) Sdn.Bhd. (2) 72.445 77.024 3.968 -
P.T.A.W.Faber Castell Ind. (2) 2.762 25.307
A.W. Faber Castell(I) Pvt. Ltd. India (2) 2.411 1.862 - -
326.552 319.839 158.756 62.811
1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Sales of goods
Migros Ticaret A.Ş. (2) 200.557 136.788 160.984 104.156
A.W.Faber-Castell Vertrieb GmbH (2) 16.577 22.656 7.835 10.686
A.W.Faber Castell Peruana (2) 2.141 4.031 1.285 4.031
Other 2.216 3.223 1.649 2.705
221.491 166.698 171.753 121.578
1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Services received
AG Anadolu Grubu Holding A.Ş. (1) 60.374 54.870 19.137 19.040
Migros Ticaret A.Ş. (2) 49.761 482 49.761 482
Anadolu Efes Spor Kulübü (2) 10.954 7.790 - -
Diğer 520 25 2 15
121.609 63.167 68.900 19.537
1 January - 1 January - 1 July - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
Services given
AEP Anadolu Etap Penkon A.Ş (2) 11.240 13.779 2.172 4.788
AEP Anadolu Etap Penkon Gıda ve Tarım Ürün San ve Tic A.Ş (2) 8.209 - 4.009 -
A.W. Faber-Castell Vetrieb Gmbh. (2) 5.831 7.589 - 7.589
Anadolu Kafkasya Enerjı Yatırımları A.Ş. (2) 3.539 3.444 1.103 1.186
Diğer 610 1.460 314 185
29.429 26.272 7.598 13.748
1 January - 1 January - 1 July -
30 September 2025 30 September 2024 30 September 2025 30 September 2024
1 July -
Other
Anadolu Eğitim ve Sosyal Yard. Vakfı (2) - 4.451 - 2.999
- 4.451 - 2.999
  • 1) Shareholders
  • 2) Other companies managed by the shareholders

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS (Continued)

c) Benefits provided to key management

The Company has determined the key management personnel as members of the board of directors, President of Agriculture Energy and Industry Group, general manager and managers reporting directly to the general manager. Benefits provided to key management personnel are as follows:

2025 2024
Short-term employee benefits 94.386 87.629
Other long-term benefits 11.697 7.281
Benefits due terminations 6.111 -
Benefits provided due to termination of employment 4.067 -
30 September 116.261 94.910

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS

(a) Capital risk management

The Company manages its capital to ensure that it will maintain its status as a going concern while maximizing the return to stakeholders through the optimization of the debt and equity balance.

The capital structure of the Company consists of debt, which includes the borrowings, cash and cash equivalents and equity attributable to equity holders of the parent, comprising issued capital, reserves and retained earnings. The management of the Company considers the cost of capital and the risks associated with each class of capital. The management of the Company aims to balance its overall capital structure through the payment of dividends, new share issues and the issue of new debt or the redemption of existing debt.

The Company controls its capital using the net debt / total equity ratio. This ratio is the calculated as net debt divided by total equity. Net debt is calculated as total liability (comprises of financial liabilities, leasing and trade payables as presented in the statement of financial position) less cash and cash equivalents. Total equity is calculated by adding shareholders equity and net debt, as shown in the balance sheet.

The Company's overall strategy based on equity does not differ from the previous period.

The Company does not have speculative financial instruments (including derivative financial instruments) and does not have any activity related to the purchase and sale of such instruments.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(a) Capital risk management (Continued)

As of September 30, 2025 and December 31, 2024, net debt / (equity + net debt) ratio is as follows;

30 September 2025 31 December 2024
Total borrowings 1.978.028 1.263.862
Less: Cash and cash equivalents (48.445) (827.004)
Net debt 1.929.583 436.858
Total equity 1.438.245 1.817.589
Total equity + net debt 3.367.828 2.254.447
Net debt / (total equity+net debt) ratio 57% 19%

(b) Credit risk

The Company's activities expose it to foreign exchange and other risks. The Company is also exposed to the risk that counterparties may not fulfill the requirements of the agreement due to holding financial instruments.

Market risks encountered at the Company level are measured on the basis of sensitivity analysis. In the current year, there has been no change compared to the previous year in the Company's exposure to market risks or in the way the Company handles or measures these risks.

(c) Currency risk and management

Transactions in foreign currency cause the exchange rate risk to occur.

The Company is exposed to exchange rate risk due to changes in the exchange rates used in the conversion of foreign currency assets and liabilities into Turkish lira. Currency risk arises due to future commercial transactions and the difference between recorded assets and liabilities.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(c) Currency risk and management (Continued)

The TRL equivalents of foreign currency assets and liabilities held by the Company are as follows:

30 September 2025 31 December 2024
Assets 48.774 82.806
Liabilities (19.144) (22.531)
Net balance sheet foreign currency position 29.630 60.275

The Company is exposed to currency risk mainly in US Dollar and Euro.

Profit/Loss 30 September 2025 Appreciation of Depreciation
foreign currency foreign currency
If the US Dollar changes 20% +/- against TRL :
1- USD net asset/liability 6.533 (6.533)
2- Part hedged against USD risk (-) (*) - -
3- USD net effect (1+2) 6.533 (6.533)
In case the Euro changes 20% +/- against TRL:
4- Euro net asset/liability (607) 607
5- Hedged portion from Euro risk (-) - -
6- Euro net effect (4+5) (607) 607
On average 20% +/- change in other exchange rates against TRL:
7- Other foreign currency net asset/liability - -
8- Hedged portion from other exchange rate risk (-) - -
9- Net effect on other FX assets (7+8) - -
5.926 (5.926)

(*) The effect of derivative instruments for hedging purposes is not taken into account.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(c) Currency risk and management (Continued)

Appreciation of Depreciation
Profit/Loss 31 December 2024 foreign currency foreign currency
If the US Dollar changes 20% +/- against TRL :
1- USD net asset/liability 11.504 (11.504)
2- Part hedged against USD risk (-) (*) - -
3- USD net effect (1+2) 11.504 (11.504)
In case the Euro changes 20% +/- against TRL:
4- Euro net asset/liability 551 (551)
5- Hedged portion from Euro risk (-) - -
6- Euro net effect (4+5) 551 (551)
On average 20% +/- change in other exchange rates against TRL:
7- Other foreign currency net asset/liability - -
8- Hedged portion from other exchange rate risk (-) - -
9- Net effect on other FX assets (7+8) - -
12.055 (12.055)

(*) The effect of derivative instruments for hedging purposes is not taken into account.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(c) Currency risk and management (Continued)

It summarizes the Company's foreign currency position risk. The recorded amounts of foreign currency assets and liabilities held by the Company are as follows. by foreign currency type:

30 September 2025 31 December 2024
TRL equivalent Thousand USD Thousand Avro Other TRL equivalent Thousand USD Thousand Avro Other
1. Trade receivables 13.378 290 28 - 18.875 285 136 -
2a. Monetary financial assets 21.913 515 11 - 44.180 1.000 - -
2b. Non-monetary financial assets - - - - - - - -
3. Other 105 - 2 - 19.751 432 15 -
4. Total current assets (1+2+3) 35.396 805 4 1 - 82.806 1.717 151 -
5. Trade receivables 13.378 290 28 - - - - -
6a. Monetary financial assets - - - - - - - -
6b. Non-monetary financial assets - - - - - - - -
7. Other - - - - - - - -
8. Total non-current assets (5+6+7) 13.378 290 2 8 - - - - -
9. Total assets (4+8) 48.774 1.095 6 9 - 82.806 1.717 151 -
10. Trade payables 19.144 308 131 - 18.217 319 90 -
11. Financial liabilities - - - - - - - -
12a. Other monetary liabilities - - - - 4.314 96 1 -
12b. Othre non-monetary liabilities - - - - - - - -
13. Total current liabilities (10+11+12) 19.144 308 131 - 22.531 415 9 1 -
14. Trade payables - - - - - - - -
15. Financial liabilities - - - - - - - -
16a. Other monetary liabilities - - - - - - - -
16b. Other non-monetary liabilities - - - - - - - -
17. Total non-current liabilities (14+15+16) - - - - - - - -
18. Total liabilities (13+17) 19.144 308 131 - 22.531 415 9 1 -
19. Net asset/ (liability) position of off-balance sheet derivative instruments
(19a-19b)
- - - - 176.722 4.000 - -
19a. Total asset amount hedged - - - - 176.722 4.000 - -
19b. Total liabilities amount hedged - - - - - - - -
20. Net foreign currency asset / (liability) position (9-18+19) 29.630 787 (62) - 236.997 5.302 6 0 -
21. Monetary items net foreign currency asset / (liability) position
(1+2a+3+5+6a-10-11-12a-14-15-16a)
29.630 787 (62) - 60.275 1.302 6 0 -
22. Total fair value of financial instruments used for currency hedge - - - - - - - -
23. Exports 113.907 1.887 618 - 158.028 2.191 696 6.680
24. Imports 530.098 9.041 3.062 4.764 575.202 10.419 3.349 9 5
% 20 increase - 6.533 (607) - - 9.172 439 -

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT SEPTEMBER 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(d) Interest rate risk and management

As of 30 September 2025, the Company does not have any floating rate borrowings. (31 December 2024: None).

(e) Credit risk management

Holding financial instruments also carries the risk that the other party will not be able to fulfill the requirements of the agreement. The Company's collection risk mainly arises from its trade receivables. Trade receivables are evaluated in accordance with the Company's policies and procedures and are recognized net of provision for doubtful receivables.

The majority of the Company's sales are for the domestic market and it is mainly carried out through dealers and wholesalers. About 54% of the sales are due to the sales of the manufactured products. The commercial goods sold by the Company are of foreign origin. Therefore the company's merchandise costs are sensitive to the exchange rate. The cost of raw materials depends on the general price trend in the country. Approximately 94% of the Company's net sales are domestically oriented and the fluctuations in exchange rates are taken into account when determining price levels.

The Company collects its receivables mainly through checks received from its dealers and also uses a direct debit system (DDS) and other collection instruments. The Company mainly uses the direct debit system (DBS) as a collection tool. Since the issuers of the checks received in general are the customers of the dealers, risk distribution is provided. Since the Company operates in this system, there is no significant risk arising from its receivables.

(f) Liquidity risk and management

The Company tries to manage its liquidity risk by regularly monitoring the cash flows and ensuring the continuation of sufficient funds and borrowing reserves by matching the maturities of financial assets and liabilities.

Liquidity risk tables

Prudent liquidity risk management refers to holding sufficient cash, availability of sufficient credit transactions and fund resources, and the power to close market positions.

The funding risk of current and prospective debt requirements is managed by maintaining the availability of sufficient number of high-quality lenders.

The maturity distribution of the Company's derivative and non-derivative financial liabilities in Turkish Lira (TRL) is presented below.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 SEPTEMBER 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 24 – FINANCIAL INSTRUMENTS

24.1 Fair value

The Company considers that the carrying values of financial instruments reflect their fair values.

Fair Value Measurements

Level 1: Market price valuation techniques for the determined financial instruments traded in markets (unadjusted)

Level 2: Other valuation techniques including direct or indirect observable inputs

Level 3: Valuation techniques not containing observable market inputs

30 September 2025 Level 1 Level 2 Level 3
Derivative financial liabilities - - - -
31 December 2024 Level 1 Level 2 Level 3
Derivative financial liabilities 704 - 704 -

24.2 Derivative financial instruments and hedge accounting

The Company has started to apply cash flow hedge accounting as of October 1, 2018.

As of September 30, 2025, the Company has a forward transaction. (31 December 2024: Nominal value of TRL 176.722 amounting to USD 4.000.000).

At the inception of a hedging transaction, the Company documents the relationship between the hedging instrument and the hedged item, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company recognizes the hedging instruments used in hedging transactions both at the inception of the hedging transaction and at regular intervals in the hedged items. whether they are highly effective in offsetting changes in their values.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 SEPTEMBER 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 24 – FINANCIAL INSTRUMENTS (Continued)

24.2 Derivative financial instruments and hedging transactions (Continued)

The Company is a party to various forward foreign exchange contracts and options depending on the management of exchange rate fluctuations. The derivative instruments purchased are mainly denominated in foreign currencies in the markets in which the Company operates for inventory purchases, purchases of machinery and equipment denominated in foreign currencies and other service contracts denominated in foreign currencies.

2025 2024
Fair Values Fair Values
Contract Amount Asset Liability Contract Amount Asset Liability
For hedging purposes:
Forward transaction - - - 176.722 - 704
- - - 176.722 - 704
Short term - - - 176.722 - 704
- - - 176.722 - 704

Objectives in financial risk management:

The Company's finance department is responsible for ensuring regular access to financial markets and monitoring and managing the financial risks incurred in connection with the Company's activities. These risks are; It includes market risk (including currency risk, fair interest rate risk and price risk), credit risk, liquidity risk and cash flow interest rate risk.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 SEPTEMBER 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 24 – FINANCIAL INSTRUMENTS (Continued)

24.2 Derivative financial instruments and hedging transactions (Continued)

The Company does not have speculative financial instruments (including derivative financial instruments) and does not have any activity related to the purchase and sale of such instruments.

Fair value differences
reflected in other
comprehensive income
Financial assets
shown at
amortized cost
Financial liabilities
shown at amortized
value
Book value Fair value
30 September 2025 Notes
Financial assets
Cash and cash equivalences 4 - 48.445 - 48.445 48.445
Trade receivables from third parties 7 - 1.136.529 - 1.136.529 1.136.529
Receivables from related parties 2 2 - 147.725 - 147.725 147.725
Other financial assets 5 - 1.564 - 1.564 1.564
Financial liabilities
Financial borrowings 6 - - 1.978.028 1.978.028 1.978.028
Lease liabilities 6 - - 112.166 112.166 112.166
Trade payables 7 - - 164.591 164.591 164.591
Payables from related parties 2 2 - - 5.357 5.357 5.357
Other financial liabilities 8 - - 9.894 9.894 9.894
Fair value differences
reflected in other
Financial assets
shown at
Financial liabilities
shown at amortized
Book value Fair value
31 December 2024 Notes comprehensive income amortized cost value
Financial assets
Cash and cash equivalences 4 - 827.004 - 827.004 827.004
Trade receivables from third parties 7 - 110.959 - 110.959 110.959
Receivables from related parties 2 2 - 53.613 - 53.613 53.613
Other financial assets 5 - 1.637 - 1.637 1.637
Financial liabilities
Financial borrowings 6 - - 1.096.237 1.096.237 1.096.237
Lease liabilities 6 - - 167.625 167.625 167.625
Trade receivables from third parties 7 - - 157.758 157.758 157.758
Payables from related parties 2 2 - - 9.017 9.017 9.017
Derivatives 24.1 - - 704 704 704

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 SEPTEMBER 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at September 30, 2025 unless otherwise indicated)

NOTE 25 – DISCLOSURES ON NET MONETARY POSITION GAINS / (LOSSES)

30 September 2025 30 September 2024
Financial Position Statement Items
Inventory 224.501 295.750
Prepaid expenses 7.118 7.716
Financial investments 23 21
Property, plant and equipment 198.915 264.030
Intangible assets 21.789 33.735
Right of use assets 19.147 46.971
Deferred tax asset - 10.153
Deferred income (11.841) 2.119
Adjustment to share capital (146.759) (191.067)
Other comprehensive expenses that will not be reclassified to profit or loss 16.206 3.749
- Losses on remeasurement of defined benefit obligations 16.206 3.749
Other comprehensive income (expenses) that will be reclassified to profit or loss (3.171) 1.881
- Currency translation differences - 1.881
- Gains (loss) on hedge (3.171) -
Restricted reserves (73.637) (99.184)
Retained earnings (132.769) (220.495)
Profit or Loss Statement Items
Revenue (124.636) (298.128)
Cost of sales (-) 72.392 125.784
Research and development expenses (-) 1.271 1.326
General administrative expenses (-) 36.573 42.253
Marketing expenses (-) 53.678 68.930
Other income from operating activities (843) (2.378)
Other expenses from operating activities (-) 1.045 2.558
Income from investment activities (5.746) (2.352)
Expenses from investment activities (-) - 4.045
Finance income (4.538) (34.623)
Finance expenses (-) 40.748 62.659
Taxes on expense - 22.447
Deferred tax income (6.093) -
Other Comprehensive Income Statement Items
Other comprehensive income (expenses) that will not be reclassified (11.649) 1.995
NET MONETARY POSITION GAINS / (LOSSES) 171.724 149.895

NOTE 26 – EVENTS AFTER THE REPORTING PERIOD

None.

…………..

Talk to a Data Expert

Have a question? We'll get back to you promptly.